Significant modulation of two bone morphogenetic proteins supports potential of ATL1102 for improving bone density in DMD
• Statistically significant mean increases in plasma BMP-5 and BMP-6 with a role in cartilage and bone formation
• Increases in mean plasma BMP-5 and BMP-6 to external healthy adult control levels are supportive of ATL1102’s potential to promote bone regeneration and improve bone density in DMD
• New proteomics data compliments previously presented data on ATL1102’s unique and highly relevant mechanism as a potential DMD treatment
Here we go.... Huge market...
Increases in mean plasma BMP-5 and BMP-6 to external healthy adult control levels are supportive of ATL1102’s potential to promote bone regeneration and improve bone density in DMD
Stay tuned for more good news....indications etc..
Significant modulation of two bone morphogenetic proteins...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.2¢ |
Change
0.002(2.22%) |
Mkt cap ! $82.94M | |||
| Open | High | Low | Value | Volume |
| 8.9¢ | 9.2¢ | 8.8¢ | $69.71K | 769.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35742 | 9.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.2¢ | 84100 | 2 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
9.2¢ |
Change
0.002 ( 3.37 %) |
||||
| Open | High | Low | Volume | ||
| 8.9¢ | 9.2¢ | 8.8¢ | 138646 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| PER (ASX) Chart |